Respiratory chain dysfunction associated with multiple mitochondrial DNA deletions in antiretroviral therapy-related lipodystrophy.
| Contribuinte(s) |
Universitat de Barcelona |
|---|---|
| Data(s) |
03/05/2013
|
| Resumo |
Highly-active antiretroviral therapy (HAART) can induce a characteristic lipodystrophy syndrome characterized by peripheral fat wasting and central adiposity, usually associated with hyperlipidaemia and insulin resistance [1,2]. Indirect data have led some authors to propose that mitochondrial dysfunction could play a role in this syndrome [3,4].To date, as recently outlined by Kakuda et al. [5] in this journal, HIV-infected patients developing lipodystrophy have not been studied for mitochondrial changes or respiratory chain capacity... |
| Identificador | |
| Idioma(s) |
eng |
| Publicador |
Lippincott Williams & Wilkins |
| Direitos |
(c) Lippincott Williams & Wilkins, 2000 info:eu-repo/semantics/openAccess |
| Palavras-Chave | #Antiretrovirals #Infeccions per VIH #Antiretroviral agents #HIV infections |
| Tipo |
info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion |